Literature DB >> 3358700

Neuropsychological impairment in Wilson's disease.

A Medalia1, K Isaacs-Glaberman, I H Scheinberg.   

Abstract

To examine the neuropsychological deficits of patients with Wilson's disease (WD), 19 neurologically impaired patients with WD were administered the Wechsler Adult Intelligence Scale (revised), Wechsler Memory Scale, Dementia Rating Scale, Wisconsin Card Sorting Test, Boston Naming Test, Trail Making Test, and Animal Naming Test. Their test scores were compared with those of 12 neurologically asymptomatic patients with WD and 15 normal controls. The neurologically impaired patients scored lower than did the control group on the Performance IQ, Full-Scale IQ, Dementia Rating Scale, and Trail Making Test, and they scored lower on the Wechsler Memory Scale than did both the asymptomatic and control groups. The major areas of deficit for the neurologically impaired WD group were in motor and memory functioning. Computed tomographic and neurologic examinations of the neurologically impaired patients with WD generally reflected abnormalities of the basal ganglia.

Entities:  

Mesh:

Year:  1988        PMID: 3358700     DOI: 10.1001/archneur.1988.00520290030009

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  12 in total

Review 1.  Amnestic disorders. Pathophysiology and patterns of memory dysfunction.

Authors:  K R Erickson
Journal:  West J Med       Date:  1990-02

2.  Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases.

Authors:  W Oder; G Grimm; H Kollegger; P Ferenci; B Schneider; L Deecke
Journal:  J Neurol       Date:  1991-08       Impact factor: 4.849

3.  Relationship between striatal glucose consumption and copper excretion in patients with Wilson's disease treated with D-penicillamine.

Authors:  H Hefter; T Kuwert; H Herzog; G Arendt; W Stremmel; L E Feinendegen
Journal:  J Neurol       Date:  1993-11       Impact factor: 4.849

Review 4.  Cognitive deficits related to major organ failure: the potential role of neuropsychological testing.

Authors:  M E Farmer
Journal:  Neuropsychol Rev       Date:  1994-06       Impact factor: 7.444

5.  Early-life metal exposure and schizophrenia: A proof-of-concept study using novel tooth-matrix biomarkers.

Authors:  A Modabbernia; E Velthorst; C Gennings; L De Haan; C Austin; A Sutterland; J Mollon; S Frangou; R Wright; M Arora; A Reichenberg
Journal:  Eur Psychiatry       Date:  2016-06-14       Impact factor: 5.361

6.  The neuropsychiatry of hyperkinetic movement disorders: insights from neuroimaging into the neural circuit bases of dysfunction.

Authors:  Bradleigh D Hayhow; Islam Hassan; Jeffrey C L Looi; Francesco Gaillard; Dennis Velakoulis; Mark Walterfang
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-08-26

7.  Social cognition in Wilson's disease: A new phenotype?

Authors:  Elodie Peyroux; Nelly Santaella; Emmanuel Broussolle; Caroline Rigard; Emilie Favre; Anne-Sophie Brunet; Muriel Bost; Alain Lachaux; Caroline Demily
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

Review 8.  Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review.

Authors:  Olivier Bonnot; Hans Hermann Klünemann; Frederic Sedel; Sylvie Tordjman; David Cohen; Mark Walterfang
Journal:  Orphanet J Rare Dis       Date:  2014-04-28       Impact factor: 4.123

Review 9.  Cognitive impairment in Wilson's disease.

Authors:  Norberto Anizio Ferreira Frota; Paulo Caramelli; Egberto Reis Barbosa
Journal:  Dement Neuropsychol       Date:  2009 Jan-Mar

10.  Which factors are associated with global cognitive impairment in Wilson's disease?

Authors:  Norberto Anízio Ferreira Frota; Egberto Reis Barbosa; Claudia Sellitto Porto; Leandro Tavares Lucato; Carla Rachel Ono; Carlos Alberto Buchpiguel; Alexandre Aluizio Costa Machado; Paulo Caramelli
Journal:  Dement Neuropsychol       Date:  2016 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.